Grantham, Mayo, Van Otterloo & Co (GMO)’s Navigant Consulting, Inc. NCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-67,912
Closed -$1.15M 650
2017
Q3
$1.15M Sell
67,912
-57,400
-46% -$971K 0.01% 366
2017
Q2
$2.48M Buy
125,312
+9,900
+9% +$209K 0.01% 307
2017
Q1
$2.64M Buy
115,412
+35,778
+45% +$853K 0.01% 297
2016
Q4
$2.08M Buy
+79,634
New +$1.88M 0.01% 313
2016
Q3
Sell
-13,100
Closed -$212K 611
2016
Q2
$212K Buy
+13,100
New +$207K ﹤0.01% 541
2014
Q3
Sell
-13,300
Closed -$232K 498
2014
Q2
$232K Sell
13,300
-400
-3% -$6.93K ﹤0.01% 463
2014
Q1
$256K Buy
+13,700
New +$247K ﹤0.01% 540

Other funds holding NCI

Grantham, Mayo, Van Otterloo & Co (GMO)'s NCI Position: Q4 2017 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Navigant Consulting, Inc. (NCI) in Q4 2017, closing a stake of 67,912 shares — an estimated $1.15M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NCI in Q1 2014 and held it in 7 quarters. The position peaked at $2.64M in Q1 2017. 161 funds tracked by Wall St. Rank hold NCI as of Q4 2017.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Navigant Consulting, Inc. position as of Q4 2017 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 67,912 Navigant Consulting, Inc. shares in Q4 2017, an estimated $1.15M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Navigant Consulting, Inc. in Q1 2014 and held it in 7 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Navigant Consulting, Inc. position peaked at $2.64M in Q1 2017.
  • 161 funds tracked by Wall St. Rank held Navigant Consulting, Inc. as of Q4 2017.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2017, filed 14 Feb 2018.